NCT07564570
- Conditions
- Behavior, Melanoma, Metastatic Melanoma, +12 more
- Locations
-
- University Medical Center Hamburg-Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany
Clinical trial condition
Skin Neoplasms
Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.
2,109 public trials
360 recruiting studies
Skin Neoplasms trial results
NCT06413680
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +28 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California San Francisco (UCSF) San Francisco, California, United States
- Yale School of Medicine North Haven, Connecticut, United States
- University of Chicago Chicago, Illinois, United States
- Conditions
- Astrocytoma, Breast Cancer, Breast Diseases, +42 more
- Locations
-
- Wuhan Union Hospital, China Wuhan, Hubei, China
NCT05522660
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
- Locations
-
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Naples, Italy
- Instituto Oncologico Veneto IRCCS Padova, Italy
- Santa Maria della Misericordia Hospital Perugia, Italy
- Istituto Nazionale Tumori "Regina Elena" Roma, Italy
NCT02333604
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +83 more
- Locations
-
- Cancer Support Community Research & Training Institute Washington D.C., District of Columbia, United States
NCT06624644
- Conditions
- Cutaneous Melanoma, Melanoma, Melanoma (Skin Cancer), +13 more
- Locations
-
- USC Newport Beach Newport Beach, California, United States
- UCSF San Francisco, California, United States
- Stanford Stanford, California, United States
- University of Colorado Anschutz Aurora, Colorado, United States
NCT07504796
- Conditions
- Advanced Melanoma, Melanoma, Metastatic Melanoma, +11 more
- Locations
-
- NYU Langone Health New York, United States
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
NCT06326411
- Conditions
- Glioma, MAPK Pathway Gene Mutation, MEK Mutation, +19 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- UCLA Hematology/Oncology Westwood, Los Angeles, California, United States
- Sarah Cannon Research Institute at Health ONE Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
NCT06270706
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumor, +64 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- South Texas Accelerated Research Therapeutics (START) Grand Rapids, Michigan, United States
- NEXT Austin Austin, Texas, United States
NCT05026983
- Conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States